EPHA2 and breast carcinoma: In conclusion, our study provides in vivo and in vitro evidences that LINC02086 acts as a tumor-promoter, enhancing cell viability and suppressing cell apoptosis in breast cancer through the regulation ofmiR-6757-5p/EPHA2 axis.